Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Phase 3 Trial

Recent news which mentions Phase 3 Trial

< Previous 1 2 3 4 5 6 7 8 Next >
Aldeyra's Dry Eye Disease Candidate Disappoints In Late-Stage Study
Tickers ALDX
Tags Briefs Movers Biotech
From Benzinga
Summit Therapeutics' Infection Candidate Flunks In Head-To-Head Trial
Tickers SMMT
Tags why it's moving Market News SMMT
From Benzinga
Novartis' Ligelizumab Suffers Setback In Late-Stage Skin Disorder Studies
Tickers NVS
Tags Briefs Movers Biotech
From Benzinga
Pfizer Submits Application For Approval Of COVID-19 Shot For Adolescents Aged 12 To 15
Tickers BNTX PFE
Tags PFE Briefs Movers
From Benzinga
Genfit Shares Rally After Ipsen Buys Rights To Its Late-Stage Kidney Disease Treatment Hopeful
Tickers GNFT IPSEF IPSEY
Tags Market News Contracts why it's moving
From Benzinga
FDA's Office Agrees On 12-Month Reduction In Pain As Primary Endpoint For Mesoblast's Back Pain Study
Tickers MESO
Tags Market News Trading Ideas Penny Stocks
From Benzinga
Valneva's COVID-19 Vaccine Booster Works As A Follow-Up To Its Own Shot
Tickers VALN
Tags why it's moving Market News News
From Benzinga
Sanofi, Glaxo's COVID-19 Vaccine Candidate Works As Booster, But Data Readout Pushed Back
Tickers AZN AZNCF BNTX GSK
Tags General COVID/19 Vaccine AZNCF
From Benzinga
After Roche Walks Away, Atea Puts Break On Late-Stage COVID-19 Oral Antiviral Trial
Tickers AVIR RHHBF RHHBY RHHVF
Tags News Health Care COVID/19 Coronavirus
From Benzinga
Roche's Polivy Combo Boosts Survival In Early-Stage Lymphoma Patients
Tickers RHHBF RHHBY RHHVF
Tags Briefs Benzinga Phase 3 Trial
From Benzinga
Cidara Therapeutics Stock Slides Despite Acing Rezafungin Trial In Fungal Infection
Tickers CDTX
Tags why it's moving Market News News
From Benzinga
Sanofi Reveals Late-Stage Data For Fitusiran In Hemophilia Patients
Tickers SNY
Tags ASH21 Market News News
From Benzinga
Why Galera Shares Are Surging More Than Double Today?
Tickers GRTX
Tags General Long Ideas Briefs
From Benzinga
Final Data Reaffirms Efficacy Of Pfizer's COVID-19 Antiviral Treatment
Tickers PFE
Tags Briefs PFE Benzinga
From Benzinga
Jazz Posts New Data for ALL/LBL Treatment At ASH 2021 Annual Meeting
Tickers JAZZ
Tags Phase 2 Trial General JAZZ
From Benzinga
Gilead's Kite Unveils More Data On Yescarta In Second-Line Lymphoma Patients
Tickers GILD
Tags GILD Market News ASH21
From Benzinga
Bristol Myers Reveals Full Data For Breyanzi In Second-Line Lymphoma Setting
Tickers BMY
Tags Market News BMY General
From Benzinga
BeiGene Unveils Results From Late-Stage Tislelizumab In Nasopharyngeal Cancer
Tickers BGNE
Tags Briefs News Biotech
From Benzinga
CSL Behring, UniQure's Hemophilia B Gene Therapy Hits Primary Endpoint
Tickers QURE
Tags Small Cap General Briefs
From Benzinga
FDA Lifts Clinical Hold On Aprea's Eprenetapopt Trial In Myeloid Malignancies
Tickers APRE
Tags News APRE Health Care
From Benzinga
Novartis Reveals Two Year Results From Beovu Trial In Diabetic Macular Edema Patients
Tickers NVS REGN
Tags General Briefs REGN
From Benzinga
Why Are Intercept Pharmaceuticals Shares Falling Today?
Tickers ICPT
Tags why it's moving Market News News
From Benzinga
Aurinia's Voclosporin Shows favorable Risk/Benefit Profile Over 3 Years In Lupus Nephritis
Tickers AUPH
Tags Movers Biotech Phase 3 Trial
From Benzinga
Novartis' New Kisqali Data Shows Consistent Overall Survival Benefit Across Metastatic Breast Cancer Settings
Tickers NVS
Tags NVS Market News breast cancer
From Benzinga
Radius Health Reveals Detailed Elacestrant Data From Late-Stage Breast Cancer Trial
Tickers RDUS
Tags News RDUS Health Care
From Benzinga
Neurocrine's Ingrezza Meets Primary Goal In Phase 3 Study In Patients With Involuntary Muscle Movement
Tickers NBIX
Tags Huntington's Disease General NBIX
From Benzinga
Can-Fite Expects Data Readout From Late-Stage Psoriasis Study With Piclidenoson In Q1 2022
Tickers AMGN CANF
Tags General Benzinga Phase 3 Trial
From Benzinga
Medicago, GSK's Plant-Based COVID-19 Vaccine Candidate Hits 75% Efficacy Against Delta Strain
Tickers GSK
Tags Market News Health Care COVID/19 Coronavirus
From Benzinga
Acadia Pharma Jumps After Rett Syndrome Candidate Aces Phase 3 Study
Tickers ACAD
Tags Phase 3 Trial ACAD Benzinga
From Benzinga
Merck Stops Enrollment In Two Islatravir Trials For Prevention Of HIV Infection
Tickers MRK
Tags Health Care News Market News
From Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.